Published in Gastroenterology on October 01, 1978
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis (2000) 6.90
The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) (1976) 4.81
Decrease in net stool output in cholera during intestinal perfusion with glucose-containing solutions. N Engl J Med (1968) 3.57
Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med (1980) 3.01
Reoperation and recurrence in Crohn's colitis and ileocolitis Crude and cumulative rates. N Engl J Med (1975) 2.59
Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut (1988) 2.51
Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology (1979) 2.48
The superior mesenteric artery syndrome. The disease that isn't, or is it? J Clin Gastroenterol (1985) 2.13
A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer (1981) 1.83
Imparied lymphocyte responsiveness in inflammatory bowel disease. Gastroenterology (1973) 1.51
Patterns of neoplasia in Crohn's disease and ulcerative colitis. Cancer (1980) 1.45
Risk factors for postoperative recurrence of Crohn's disease. Gastroenterology (1983) 1.43
Prostanoid synthesis by cultured intestinal epithelial and mononuclear cells in inflammatory bowel disease. Gut (1983) 1.42
Sera-reactivity in inflammatory bowel disease: frequency of recognition of Crohn's disease tissue primed nude mouse lymphoid tissue in an interinstitutional blinded study. J Clin Gastroenterol (1989) 1.40
ACTH-induced adrenal hemorrhage: a complication of therapy masquerading as an acute abdomen. J Clin Gastroenterol (1990) 1.40
Extraintestinal cancers in inflammatory bowel disease. Cancer (1985) 1.34
Intestinal transmural electric potential and its response to glucose in acute and convalescent cholera. Gastroenterology (1969) 1.27
Free perforation in Crohn's disease: I. A survey of 99 cases. Am J Gastroenterol (1985) 1.23
Carcinoid tumor and inflammatory bowel disease: a study of eleven cases and review of the literature. Am J Gastroenterol (1997) 1.21
Cricopharyngeal myotomy: management of cervical dysphagia. Otolaryngol Head Neck Surg (1983) 1.20
Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine. A prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial. Gastroenterology (1987) 1.19
The role of the fecal stream in Crohn's disease: an historical and analytic review. Inflamm Bowel Dis (1998) 1.19
Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis-cancer interval. Gut (1991) 1.15
Benign and malignant colorectal strictures in ulcerative colitis. Gut (1992) 1.13
Severe gastrointestinal hemorrhage in Crohn's disease. Ann Surg (1991) 1.11
Ulcerative colitis practice guidelines in adults. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol (1997) 1.11
Granulomas do not affect postoperative recurrence rates in Crohn's disease. Gastroenterology (1982) 1.10
A comparison of multiple synchronous colorectal cancer in ulcerative colitis, familial polyposis coli, and de novo cancer. Ann Surg (1986) 1.09
Neuroleptic malignant syndrome induced by domperidone. Dig Dis Sci (1992) 1.09
Erythrocytic sedimentation rate as a measure of clinical activity in inflammatory bowel disease. J Clin Gastroenterol (1986) 1.08
Spontaneous free perforation and perforated abscess in 30 patients with Crohn's disease. Ann Surg (1987) 1.08
Outcome of toxic dilatation in ulcerative and Crohn's colitis. J Clin Gastroenterol (1985) 1.07
T and B lymphocytes and cutaneous anergy in inflammatory bowel disease. Ann N Y Acad Sci (1976) 1.07
Clinical and colonoscopic surveillance in ulcerative colitis: are we saving colons or saving lives? Gastroenterology (1993) 1.06
Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease. Aliment Pharmacol Ther (2011) 1.05
Surgical treatment, skin test reactivity, and lymphocytes in inflammatory bowel disease. Am J Surg (1983) 1.04
Lymphoma in inflammatory bowel disease. Cancer (1992) 1.03
Amyloidosis and inflammatory bowel disease. A 50-year experience with 25 patients. Medicine (Baltimore) (1992) 1.01
Medical management of Crohn's disease. Hepatogastroenterology (1990) 1.00
Quality of life after surgery for Crohn's disease: a psychosocial survey. Gastroenterology (1980) 0.99
Management of severe hemorrhage in ulcerative colitis. Am J Surg (1990) 0.97
Budesonide for inflammatory bowel disease. It is a magic bullet? N Engl J Med (1994) 0.96
Course of enterovesical fistulas in Crohn's disease. Am J Surg (1984) 0.95
Intraabdominal abscess in Crohn's (ileo) colitis. Am J Surg (1982) 0.95
Enterolithiasis, refractory anemia, and strictures of Crohn's disease. J Clin Gastroenterol (1994) 0.95
Gastric fistulas in Crohn's disease. Report of cases. Dis Colon Rectum (1989) 0.93
Cancer in universal and left-sided ulcerative colitis: clinical and pathologic features. Mt Sinai J Med (1979) 0.92
Androgenic steroids and hepatocellular carcinoma. Lancet (1973) 0.92
Malignant colorectal strictures in Crohn's disease. Am J Gastroenterol (1991) 0.92
Symptomatic differentiation of duodenal from gastric fistulas in Crohn's disease. Am J Gastroenterol (1990) 0.92
Letter: Lymphocyte responsiveness in inflammatory bowel disease. Gastroenterology (1975) 0.91
Duodenal fistulas in Crohn's disease. J Clin Gastroenterol (1987) 0.91
Acute myelogenous leukemia in patients with ulcerative colitis. J Clin Gastroenterol (1980) 0.89
Circulating carcinoembryonic antigen (CEA): relationship to clinical status of patients with inflammatory bowel disease. Gut (1973) 0.89
Survival with colorectal cancer in ulcerative colitis. A study of 102 cases. Ann Surg (1993) 0.88
Crohn's disease: a family affair. Gastroenterology (1996) 0.88
Small bowel carcinoma in Crohn's disease. Distinguishing features and risk factors. Cancer (1989) 0.88
New concepts of cancer. Mt Sinai J Med (1983) 0.87
Correlation between fluorescent antibody detection of hepatitis B core antigen in liver biopsies and the presence of e antigen in serum. Infect Immun (1976) 0.87
Toxic megacolon in ulcerative colitis complicated by pneumomediastinum: report of two cases. Gastroenterology (1980) 0.87
Surgery for ulcerative colitis in elderly persons: changes in indications for surgery and outcome over time. Arch Surg (2001) 0.86
Aetiological theories of inflammatory bowel disease. Clin Gastroenterol (1980) 0.85
The electronic video endoscope: clinical experience with 1200 diagnostic and therapeutic cases in the community hospital. Gastrointest Endosc (1987) 0.85
Editorial: A transmissible agent in Crohn's disease? New pursuit of an old concept. N Engl J Med (1975) 0.84
Erosive syphilitic gastritis: dark-field and immunofluorescent diagnosis from biopsy specimen. Ann Intern Med (1974) 0.84
Sialosyl-Tn antigen is prevalent and precedes dysplasia in ulcerative colitis: a retrospective case-control study. Gastroenterology (1996) 0.83
Predicting relapses of Crohn's disease. Clouds in the crystal ball. Dig Dis Sci (1987) 0.83
Corticotropin versus hydrocortisone in the intravenous treatment of ulcerative colitis. A prospective, randomized, double-blind clinical trial. Gastroenterology (1983) 0.83
Vigorous medical management of acute fulminant hepatitis. Arch Intern Med (1977) 0.83
Pancreatic tuberculosis: a frequently fatal but potentially curable disease. J Clin Gastroenterol (1990) 0.83
Cancer in ulcerative colitis: good news and bad news. Ann Intern Med (1981) 0.82
Metronidazole for Crohn's disease--breakthrough or ballyhoo? Gastroenterology (1980) 0.81
Olsalazine in the treatment of ulcerative colitis among patients intolerant of sulphasalazine: a prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial. Scand J Gastroenterol Suppl (1988) 0.81
Adenocarcinoma complicating restorative proctocolectomy for ulcerative colitis with mucosectomy performed by Cavitron Ultrasonic Surgical Aspirator. Colorectal Dis (2008) 0.81
Free colonic perforation without dilatation in ulcerative colitis. Am J Surg (1986) 0.81
Significance of anergy to dinitrochlorobenzene (DNCB) in inflammatory bowel disease: family and postoperative studies. Gut (1978) 0.81
Crohn's disease in Cleveland: a matter of life and death. Gastroenterology (1985) 0.80
Loss of suppressor T-cells in active inflammatory bowel disease. Gut (1984) 0.80
Studies of the "e" antigen in acute and chronic hepatitis. Gastroenterology (1976) 0.79
Sialosyl-Tn antigen: initial report of a new marker of malignant progression in long-standing ulcerative colitis. Gastroenterology (1995) 0.79
Management of varicella infection during the course of inflammatory bowel disease. Am J Gastroenterol (1997) 0.79
Letter: B lymphocytes in inflammatory bowel disease. Lancet (1974) 0.79
Anergy in Crohn's disease. Br Med J (1977) 0.79
Stricture of the anorectum in Crohn's disease involving the colon. Ann Surg (1975) 0.78
Immunotherapy in inflammatory bowel disease. Med Clin North Am (1978) 0.78
Pyogenic liver abscess in Crohn's disease. Q J Med (1985) 0.78
New observations in Crohn's disease. Annu Rev Med (1976) 0.78
Hepatic pathologic condition in asymptomatic Australia antigen carriers. A light microscopical study of 26 cases and a review of the literature. Arch Pathol Lab Med (1977) 0.78
Drug therapy of acute pancreatitis. Clin Gastroenterol (1979) 0.78
Behaviour of Crohn's disease according to the Vienna classification. Gut (2002) 0.78
Placebo-controlled clinical trials in gastroenterology. A position paper of the American College of Gastroenterology. Am J Gastroenterol (1984) 0.78
Colorectal adenocarcinoma in Crohn's disease. Ann Surg (1996) 0.78
Malignant melanoma in inflammatory bowel disease. Am J Gastroenterol (1992) 0.78
Extraintestinal manifestations in patients with diverticulitis. Ann Intern Med (1988) 0.78
Refractory pouchitis: does it reflect underlying Crohn's disease? Gut (1993) 0.77
Recurrence and regeneration in Crohn's colitis. Gastroenterology (1978) 0.77
Toxic dilatation in amebic colitis: successful treatment without colectomy. Am J Surg (1980) 0.76
Animal transmission models. Mt Sinai J Med (1983) 0.76
Coombs-positive autoimmune hemolytic anemia in ulcerative colitis. Dig Dis Sci (1989) 0.76